Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

IMMULOGIC FILES FOR 2 MILLION-SHARE OFFERING

Dec. 23, 1991

VIMRX FILES FOR OFFERING

Dec. 23, 1991

ONCOGENE RAISES $17.1 MILLION IN OFFERING

Dec. 23, 1991

ANALYST REDUCES RATING ON BIOGEN

Dec. 23, 1991

IDEXX RENEGOTIATES ACQUISITION

Dec. 23, 1991

CHIEF SCIENTIFIC OFFICER LEAVES LIDAK

Dec. 23, 1991

DYNAGEN LICENSES TB ANTIBODIES

Dec. 23, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 23, 1991

BTGC GROSSES $13 MILLION IN STOCK SALE

Dec. 23, 1991

LOW-TECH SEPTIC SHOCK TREATMENT

Dec. 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...